Richard Jacroux - 08 Aug 2024 Form 3 Insider Report for ENDRA Life Sciences Inc. (NDRA)

Signature
/s/ Richard Jacroux by Coleman Wombwell, attorney-in-fact
Issuer symbol
NDRA
Transactions as of
08 Aug 2024
Net transactions value
$0
Form type
3
Filing time
15 Aug 2024, 17:00:03 UTC
Next filing
23 Jan 2026

No securities are beneficially owned.

Remarks:

No securities beneficially owned.